Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Brucella suis biovar 1 (strain 1330) | Histidinol dehydrogenase | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Mycobacterium leprae | Probable histidinol dehydrogenase HisD (HDH) | Get druggable targets OG5_129099 | All targets in OG5_129099 |
Candida albicans | Phosphoribosyl-AMP cyclohydrolase | Get druggable targets OG5_129099 | All targets in OG5_129099 |
Mycobacterium ulcerans | histidinol dehydrogenase | Get druggable targets OG5_129099 | All targets in OG5_129099 |
Mycobacterium tuberculosis | Probable histidinol dehydrogenase HisD (HDH) | Get druggable targets OG5_129099 | All targets in OG5_129099 |
Candida albicans | Phosphoribosyl-AMP cyclohydrolase | Get druggable targets OG5_129099 | All targets in OG5_129099 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | CAMK family protein kinase | 0.0053 | 0 | 0.5 |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0053 | 0 | 0.5 |
Toxoplasma gondii | histone kinase SNF1, putative | 0.0053 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0053 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0053 | 0 | 0.5 |
Giardia lamblia | Kinase, CAMK CAMKL | 0.0053 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0053 | 0 | 0.5 |
Leishmania major | serine/threonine protein kinase, putative,protein kinase, putative | 0.0053 | 0 | 0.5 |
Echinococcus multilocularis | 5' AMP activated protein kinase catalytic | 0.0276 | 0.2704 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0053 | 0 | 0.5 |
Trypanosoma cruzi | SNF1-related protein kinases, putative | 0.0053 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0053 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0053 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0053 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0053 | 0 | 0.5 |
Mycobacterium ulcerans | histidinol dehydrogenase | 0.0876 | 1 | 0.5 |
Brugia malayi | EST embl|AI107989|AI107989 comes from the 3' UTR, putative | 0.0276 | 0.2704 | 1 |
Loa Loa (eye worm) | CAMK/CAMKL/AMPK protein kinase | 0.0276 | 0.2704 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0053 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0053 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0053 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0053 | 0 | 0.5 |
Plasmodium vivax | serine/threonine protein kinase KIN, putative | 0.0053 | 0 | 0.5 |
Plasmodium falciparum | serine/threonine protein kinase KIN | 0.0053 | 0 | 0.5 |
Echinococcus granulosus | 5' AMP activated protein kinase catalytic | 0.0276 | 0.2704 | 1 |
Trypanosoma brucei | SNF1-related protein kinases, putative | 0.0053 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0053 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0053 | 0 | 0.5 |
Giardia lamblia | Kinase, CAMK CAMKL | 0.0053 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable histidinol dehydrogenase HisD (HDH) | 0.0876 | 1 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0276 | 0.2704 | 1 |
Leishmania major | protein kinase, putative,SNF1-related protein kinases, putative | 0.0053 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0053 | 0 | 0.5 |
Trypanosoma cruzi | 5'-AMP-activated protein kinase catalytic subunit alpha, putative | 0.0053 | 0 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0053 | 0 | 0.5 |
Trypanosoma brucei | 5'-AMP-activated protein kinase catalytic subunit alpha, putative | 0.0053 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 2.78 uM | Inhibition of Brucella suis 1330 His6-tagged HDH expressed in Escherichia coli BL21 (DE3) using L-histidinol as substrate assessed as NADH formation preincubated for 5 mins followed by substrate addition | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.